The global biotechnology market is estimated to reach USD 2,267.77 billion by 2028 growing at a CAGR of 15.5% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Biotechnology Market Share, Size, Trends & Industry Analysis Report By Technology (Fermentation, Tissue Engineering and Regeneration, PCR Technology, Nanobiotechnology, Chromatography, DNA Sequencing, Cell Based Assays); By Application; and By Region; Segment Forecast, 2021 – 2028’ provides an extensive analysis of present market dynamics and predicted future trends.
Growing hepatitis B disease, increasing interest in horticultural items such as sugarcane, rice, beans, and wheat due to the increasing populations in economies such as the U.S., China, and India are expected to push the overall biotechnology market.
The growth of this market is further propelled by elements such as deficiency of water, low yield of items, insect attacks, and constrained availability of agrarian land, which is promoting the companies to invest and conduct R&D activities at a broader scale. Another factor that is helping the market growth includes regenerative medicines.
The existence of a huge section of businesses concentrating on the advancement of regenerative treatments is anticipated to push the market development through to 2026. Technological developments in the areas of artificial intelligence are estimated to sustain progress with possible opportunities. The companies are engaged in using artificial intelligence in order to understand cancer cases while working on medical trials.
Encouraging government policies associated with biological advancements is also propelling the demand growth. Established economies such as the U.S. and UK and growing economies such as China and India are investing in biotechnology R&D initiatives. Governments are associating with private companies for expanding their research into this domain.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:https://www.polarismarketresearch.com/industry-analysis/biotechnology-market
Owing to technological improvements and prevalent applications of biotechnology in healthcare is helping the market to gain strong growth during the forecast period. Companies are constantly introducing brand-new biotechnological medicines and vaccines to deal with diagnosis and biopharmaceutical development within the healthcare sector, which is approximated to push the market further towards its growth.
Bioinformatics is anticipated to witness the fastest growth in the coming years. Developments in data combination tools through cloud computing platforms facilitate analysis and assistance to process enormous next-generation sequencing information. These advancements are approximated to greatly boost the adoption of bioinformatics tools in numerous life sciences applications in the near future.
The application of nanotechnology-based products is anticipated to improve development in this sector. Reducing costs and increase in the number of services related to biotechnology are expected to drive the growth with profitable avenues.
North American pharma and biotech organizations have experienced excellent success in the last couple of years resulting in a larger revenue share. Universities and research institutes are also introducing various biotech-based programs which would help the industry to gain much-required traction.
The Asia Pacific industry on the other hand is anticipated to grow at the most significant rate due to improving and growing healthcare infrastructure coupled with local companies in this region focusing on developing advanced medicines to cure chronic diseases such as cancer with the help of biotechnology. Strong government and federal assistance and recruitment of extremely trained researchers have made it possible for countries such as China and India to swiftly develop capacity for regenerative medication.
Some of the major players operating in this market include Abbott Laboratories, Agilent Technologies, Amgen, BioGen Medical Instruments, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen, Thermo Fisher Scientific, Gilead, Celgene, Novo Nordisk A/S, Novartis AG, Sanofi Aventis, and Lonza.
Polaris Market Research has segmented the global biotechnology market on the basis of technology, application, and region:
Biotechnology Technology Outlook (Revenue, USD Billion, 2016 – 2028)
- DNA Sequencing
- Tissue regeneration and engineering
- PCR technology
- Cell-based assays
Biotechnology Application Outlook (Revenue, USD Billion, 2016 – 2028)
Biotechnology Regional Outlook (Revenue, USD Billion, 2016 – 2028)
- North America
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa